Noncoding RNAs and the control of hormonal signaling via nuclear receptor regulation

Journal of Molecular Endocrinology

Volumn 53, Issue 2, 2014, Pages R61-R70

  Ottaviani, Silvia ^a   de Giorgio, Alexander ^a   Harding, Victoria ^a   Stebbing, Justin ^a   Castellano, Leandro ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

ERNA; LncRNA; MicroRNA; MiRNA; Noncoding RNA; Nuclear receptors

Indexed keywords

ANDROGEN RECEPTOR; CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR ALPHA; LONG UNTRANSLATED RNA; MICRORNA; STEROID RECEPTOR; UNTRANSLATED RNA; CELL RECEPTOR; HORMONE;

CELL PROLIFERATION; ENHANCER REGION; EPITHELIAL MESENCHYMAL TRANSITION; GENE ACTIVATION; GENE EXPRESSION; HISTONE MODIFICATION; HUMAN; NEGATIVE FEEDBACK; NONHUMAN; ONCOGENE C MYC; PROMOTER REGION; PROSTATE CANCER; PROTEIN PROCESSING; PROTEIN SECONDARY STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION ELONGATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

ANIMALS; GENE EXPRESSION REGULATION; HORMONES; HUMANS; MICRORNAS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, LONG NONCODING; RNA, UNTRANSLATED; SIGNAL TRANSDUCTION;

EID: 84907990887     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-14-0134     Document Type: Review

References (106)

1. Acevedo ML & Kraus WL 2004 Transcriptional activation by nuclear receptors. Essays in Biochemistry 40 73-88.
2. Adams BD, Furneaux H & White BA 2007 The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-a (ERa) and represses ERa messenger RNA and protein expression in breast cancer cell lines. Molecular Endocrinology 21 1132-1147. (doi:10.1210/me.2007-0022)
3. Adams BD, Claffey KP & White BA 2009 Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells. Endocrinology 150 14-23. (doi:10.1210/en.2008-0984)
4. Agoulnik IU & Weigel NL 2009 Coactivator selective regulation of androgen receptor activity. Steroids 74 669-674. (doi:10.1016/j.steroids.2009.02.007)
5. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA et al. 2008 Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Research 68 6162-6170. (doi:10.1158/0008-5472.CAN-08-0144)
6. Bartel DP 2009 MicroRNAs: target recognition and regulatory functions. Cell 136 215-233. (doi:10.1016/j.cell.2009.01.002)
7. Batista PJ & Chang HY 2013 Long noncoding RNAs: cellular address codes in development and disease. Cell 152 1298-1307. (doi:10.1016/j.cell.2013.02.012)
8. Bazzini AA, Johnstone TG, Christiano R, Mackowiak SD, Obermayer B, Fleming ES, Vejnar CE, Lee MT, Rajewsky N, Walther TC et al. 2014 Identification of small ORFs in vertebrates using ribosome footprinting and evolutionary conservation. EMBO Journal 33 981-993. (doi:10.1002/embj.201488411)
9. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C & Snyder M 2012 An integrated encyclopedia of DNA elements in the human genome. Nature 489 57-74. (doi:10.1038/nature11247)
10. Bhat-Nakshatri P, Wang G, Collins NR, Thomson MJ, Geistlinger TR, Carroll JS, Brown M, Hammond S, Srour EF, Liu Y et al. 2009 Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Research 37 4850-4861. (doi:10.1093/nar/gkp500)
11. Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis ET, Thurman RE et al. 2007 Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447 799-816. (doi:10.1038/nature05874)
12. Brase JC, Johannes M, Schlomm T, Falth M, Haese A, Steuber T, Beissbarth T, Kuner R & Sultmann H 2011 Circulating miRNAs are correlated with tumor progression in prostate cancer. International Journal Cancer 128 608-616. (doi:10.1002/ijc.25376)
13. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C et al. 2005 The transcriptional landscape of the mammalian genome. Science 309 1559-1563. (doi:10.1126/science.1112014)
14. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR et al. 2005 Chromosomewide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122 33-43. (doi:10.1016/j.cell.2005.05.008)
15. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF et al. 2006 Genome-wide analysis of estrogen receptor binding sites. Nature Genetics 38 1289-1297. (doi:10.1038/ng1901)
16. Castellano L, Giamas G, Jacob J, Coombes RC, Lucchesi W, Thiruchelvam P, Barton G, Jiao LR, Wait R, Waxman J et al. 2009 The estrogen receptora-induced microRNA signature regulates itself and its transcriptional response. PNAS 106 15732-15737. (doi:10.1073/pnas.0906947106)
17. Cheng C, Fu X, Alves P & Gerstein M 2009 mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer. Genome Biology 10 R90. (doi:10.1186/gb-2009-10-9-r90)
18. Cheung E & Kraus WL 2010 Genomic analyses of hormone signaling and gene regulation. Annual Review of Physiology 72 191-218. (doi:10.1146/annurev-physiol-021909-135840)
19. Cochrane DR, Cittelly DM & Richer JK 2011 Steroid receptors and microRNAs: relationships revealed. Steroids 76 1-10. (doi:10.1016/j.steroids.2010.11.003)
20. Cooper C, Guo J, Yan Y, Chooniedass-Kothari S, Hube F, Hamedani MK, Murphy LC, Myal Y & Leygue E 2009 Increasing the relative expression of endogenous non-coding steroid receptor RNA activator (SRA) in human breast cancer cells using modified oligonucleotides. Nucleic Acids Research 37 4518-4531. (doi:10.1093/nar/gkp441)
21. Core LJ, Waterfall JJ & Lis JT 2008 Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 322 1845-1848. (doi:10.1126/science.1162228)
22. Cui W, Li Q, Feng L & Ding W 2011 MiR-126-3p regulates progesterone receptors and involves development and lactation of mouse mammary gland. Molecular and Cellular Biochemistry 355 17-25. (doi:10.1007/s11010-011-0834-1)
23. Denayer S, Helsen C, Thorrez L, Haelens A & Claessens F 2010 The rules of DNA recognition by the androgen receptor. Molecular Endocrinology 24 898-913. (doi:10.1210/me.2009-0310)
24. De Santa F, Barozzi I, Mietton F, Ghisletti S, Polletti S, Tusi BK, Muller H, Ragoussis J, Wei CL & Natoli G 2010 A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biology 8 e1000384. (doi:10.1371/journal.pbio.1000384)
25. Dinger ME, Gascoigne DK & Mattick JS 2011 The evolution of RNAs with multiple functions. Biochimie 93 2013-2018. (doi:10.1016/j.biochi.2011.07.018)
26. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F et al. 2012 Landscape of transcription in human cells. Nature 489 101-108. (doi:10.1038/nature11233)
27. Emberley E, Huang GJ, Hamedani MK, Czosnek A, Ali D, Grolla A, Lu B, Watson PH, Murphy LC & Leygue E 2003 Identification of new human coding steroid receptor RNA activator isoforms. Biochemical and Biophysical Research Communications 301 509-515. (doi:10.1016/S0006-291X(02)03070-X)
28. Fabian MR, Sonenberg N & Filipowicz W 2010 Regulation of mRNA translation and stability by microRNAs. Annual Review of Biochemistry 79 351-379. (doi:10.1146/annurev-biochem-060308-103103)
29. Fletcher CE, Dart DA, Sita-Lumsden A, Cheng H, Rennie PS & Bevan CL 2012 Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer. Human Molecular Genetics 21 3112-3127. (doi:10.1093/hmg/dds139)
30. Gadaleta RM & Magnani L 2014 Nuclear receptors and chromatin: an inducible couple. Journal of Molecular Endocrinology 52 R137-R149. (doi:10.1530/JME-13-0170)
31. Gandellini P, Folini M, Longoni N, Pennati M, Binda M, Colecchia M, Salvioni R, Supino R, Moretti R, Limonta P et al. 2009 miR-205 exerts tumor-suppressive functions in human prostate through downregulation of protein kinase Cepsilon. Cancer Research 69 2287-2295. (doi:10.1158/0008-5472.CAN-08-2894)
32. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y & Goodall GJ 2008 The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nature Cell Biology 10 593-601. (doi:10.1038/ncb1722)
33. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL et al. 2010 Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464 1071-1076. (doi:10.1038/nature08975)
34. Guttman M & Rinn JL 2012 Modular regulatory principles of large non-coding RNAs. Nature 482 339-346. (doi:10.1038/nature10887)
35. Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP et al. 2009 Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458 223-227. (doi:10.1038/nature07672)
36. Guttman M, Russell P, Ingolia NT, Weissman JS & Lander ES 2013 Ribosome profiling provides evidence that large noncoding RNAs do not encode proteins. Cell 154 240-251. (doi:10.1016/j.cell.2013.06.009)
37. Hah N, Danko CG, Core L, Waterfall JJ, Siepel A, Lis JT & Kraus WL 2011 A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells. Cell 145 622-634. (doi:10.1016/j.cell.2011.03.042)
38. Hah N, Murakami S, Nagari A, Danko CG & Kraus WL 2013 Enhancer transcripts mark active estrogen receptor binding sites. Genome Research 23 1210-1223. (doi:10.1101/gr.152306.112)
39. Hatchell EC, Colley SM, Beveridge DJ, Epis MR, Stuart LM, Giles KM, Redfern AD, Miles LE, Barker A, MacDonald LM et al. 2006 SLIRP, a small SRA binding protein, is a nuclear receptor corepressor. Molecular Cell 22 657-668. (doi:10.1016/j.molcel.2006.05.024)
40. Heldring N, Isaacs GD, Diehl AG, Sun M, Cheung E, Ranish JA & Kraus WL 2011 Multiple sequence-specific DNA-binding proteins mediate estrogen receptor signaling through a tethering pathway. Molecular Endocrinology 25 564-574. (doi:10.1210/me.2010-0425)
41. Helsen C & Claessens F 2014 Looking at nuclear receptors from a new angle. Molecular and Cellular Endocrinology 382 97-106. (doi:10.1016/j.mce.2013.09.009)
42. Helsen C, Kerkhofs S, Clinckemalie L, Spans L, Laurent M, Boonen S, Vanderschueren D & Claessens F 2012 Structural basis for nuclear hormone receptor DNA binding. Molecular and Cellular Endocrinology 348 411-417. (doi:10.1016/j.mce.2011.07.025)
43. Helwak A, Kudla G, Dudnakova T & Tollervey D 2013 Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153 654-665. (doi:10.1016/j.cell.2013.03.043)
44. Hirose T, Mishima Y & Tomari Y 2014 Elements and machinery of non-coding RNAs: toward their taxonomy. EMBO Reports 15 489-507. (doi:10.1002/embr.201338390)
45. Hsieh CL, Fei T, Chen Y, Li T, Gao Y, Wang X, Sun T, Sweeney CJ, Lee GS, Chen S et al. 2014 Enhancer RNAs participate in androgen receptordriven looping that selectively enhances gene activation. PNAS 111 7319-7324. (doi:10.1073/pnas.1324151111)
46. Hulf T, Sibbritt T, Wiklund ED, Patterson K, Song JZ, Stirzaker C, Qu W, Nair S, Horvath LG, Armstrong NJ et al. 2013 Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer. Oncogene 32 2891-2899. (doi:10.1038/onc.2012.300)
47. Kagey MH, Newman JJ, Bilodeau S, Zhan Y, Orlando DA, van Berkum NL, Ebmeier CC, Goossens J, Rahl PB, Levine SS et al. 2010 Mediator and cohesin connect gene expression and chromatin architecture. Nature 467 430-435. (doi:10.1038/nature09380)
48. Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, Stadler PF, Hertel J, Hackermuller J, Hofacker IL et al. 2007 RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 316 1484-1488. (doi:10.1126/science.1138341)
49. Kawashima H, Takano H, Sugita S, Takahara Y, Sugimura K & Nakatani T 2003 A novel steroid receptor co-activator protein (SRAP) as an alternative form of steroid receptor RNA-activator gene: expression in prostate cancer cells and enhancement of androgen receptor activity. Biochemical Journal 369 163-171. (doi:10.1042/BJ20020743)
50. Kerkhofs S, Dubois V, De Gendt K, Helsen C, Clinckemalie L, Spans L, Schuit F, Boonen S, Vanderschueren D, Saunders PT et al. 2012 A role for selective androgen response elements in the development of the epididymis and the androgen control of the 5a reductase II gene. FASEB Journal 26 4360-4372. (doi:10.1096/fj.11-202283)
51. Kim TK, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, Harmin DA, Laptewicz M, Barbara-Haley K, Kuersten S et al. 2010 Widespread transcription at neuronal activity-regulated enhancers. Nature 465 182-187. (doi:10.1038/nature09033)
52. Kino T, Hurt DE, Ichijo T, Nader N & Chrousos GP 2010 Noncoding RNA Gas5 is a growth arrest-and starvation-associated repressor of the glucocorticoid receptor. Science Signaling 3 ra8. (doi:10.1126/scisignal.2000568)
53. Koch F, Fenouil R, Gut M, Cauchy P, Albert TK, Zacarias-Cabeza J, Spicuglia S, de la Chapelle AL, Heidemann M, Hintermair C et al. 2011 Transcription initiation platforms and GTF recruitment at tissue-specific enhancers and promoters. Nature Structural & Molecular Biology 18 956-963. (doi:10.1038/nsmb.2085)
54. Krol J, Loedige I & Filipowicz W 2010 The widespread regulation of microRNA biogenesis, function and decay. Nature Reviews. Genetics 11 597-610. (doi:10.1038/nrg2843)
55. Lai CF, Flach KD, Alexi X, Fox SP, Ottaviani S, Thiruchelvam PT, Kyle FJ, Thomas RS, Launchbury R, Hua H et al. 2013 Co-regulated gene expression by oestrogen receptor a and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells. Nucleic Acids Research 41 10228-10240. (doi:10.1093/nar/gkt827)
56. Lam MT, Cho H, Lesch HP, Gosselin D, Heinz S, Tanaka-Oishi Y, Benner C, Kaikkonen MU, Kim AS, Kosaka M et al. 2013 Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature 498 511-515. (doi:10.1038/nature12209)
57. Lanz RB, McKenna NJ, Onate SA, Albrecht U, Wong J, Tsai SY, Tsai MJ & O’Malley BW 1999 A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97 17-27. (doi:10.1016/S0092-8674(00)80711-4)
58. Lanz RB, Razani B, Goldberg AD & O’Malley BW 2002 Distinct RNA motifs are important for coactivation of steroid hormone receptors by steroid receptor RNA activator (SRA). PNAS 99 16081-16086. (doi:10.1073/pnas.192571399)
59. Lanz RB, Chua SS, Barron N, Soder BM, DeMayo F & O’Malley BW 2003 Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo. Molecular and Cellular Biology 23 7163-7176. (doi:10.1128/MCB.23.20.7163-7176.2003)
60. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH & Kim VN 2004 MicroRNA genes are transcribed by RNA polymerase II. EMBO Journal 23 4051-4060. (doi:10.1038/sj.emboj.7600385)
61. Leivonen SK, Makela R, Ostling P, Kohonen P, Haapa-Paananen S, Kleivi K, Enerly E, Aakula A, Hellstrom K, Sahlberg N et al. 2009 Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines. Oncogene 28 3926-3936. (doi:10.1038/onc.2009.241)
62. Lewis BP, Burge CB & Bartel DP 2005 Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 15-20. (doi:10.1016/j.cell.2004.12.035)
63. Leygue E, Dotzlaw H, Watson PH & Murphy LC 1999 Expression of the steroid receptor RNA activator in human breast tumors. Cancer Research 59 4190-4193.
64. Li W, Notani D, Ma Q, Tanasa B, Nunez E, Chen AY, Merkurjev D, Zhang J, Ohgi K, Song X et al. 2013 Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature 498 516-520. (doi:10.1038/nature12210)
65. Magny EG, Pueyo JI, Pearl FM, Cespedes MA, Niven JE, Bishop SA & Couso JP 2013 Conserved regulation of cardiac calcium uptake by peptides encoded in small open reading frames. Science 341 1116-1120. (doi:10.1126/science.1238802)
66. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P et al. 1995 The nuclear receptor superfamily: the second decade. Cell 83 835-839. (doi:10.1016/0092-8674(95)90199-X)
67. Matera AG, Terns RM & Terns MP 2007 Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs. Nature Reviews. Molecular Cell Biology 8 209-220. (doi:10.1038/nrm2124)
68. Mercer TR & Mattick JS 2013 Structure and function of long noncoding RNAs in epigenetic regulation. Nature Structural & Molecular Biology 20 300-307. (doi:10.1038/nsmb.2480)
69. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A et al. 2008 Circulating microRNAs as stable blood-based markers for cancer detection. PNAS 105 10513-10518. (doi:10.1073/pnas.0804549105)
70. Mourtada-Maarabouni M, Pickard MR, Hedge VL, Farzaneh F & Williams GT 2009 GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 28 195-208. (doi:10.1038/onc.2008.373)
71. Murphy LC, Simon SL, Parkes A, Leygue E, Dotzlaw H, Snell L, Troup S, Adeyinka A & Watson PH 2000 Altered expression of estrogen receptor coregulators during human breast tumorigenesis. Cancer Research 60 6266-6271.
72. Natoli G & Andrau JC 2012 Noncoding transcription at enhancers: general principles and functional models. Annual Review of Genetics 46 1-19. (doi:10.1146/annurev-genet-110711-155459)
73. Novikova IV, Hennelly SP & Sanbonmatsu KY 2012 Structural architecture of the human long non-coding RNA, steroid receptor RNA activator. Nucleic Acids Research 40 5034-5051. (doi:10.1093/nar/gks071)
74. Orom UA & Shiekhattar R 2011 Noncoding RNAs and enhancers: complications of a long-distance relationship. Trends in Genetics 27 433-439. (doi:10.1016/j.tig.2011.06.009)
75. Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q et al. 2010 Long noncoding RNAs with enhancer-like function in human cells. Cell 143 46-58. (doi:10.1016/j.cell.2010.09.001)
76. Ostling P, Leivonen SK, Aakula A, Kohonen P, Makela R, Hagman Z, Edsjo A, Kangaspeska S, Edgren H, Nicorici D et al. 2011 Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells. Cancer Research 71 1956-1967. (doi:10.1158/0008-5472.CAN-10-2421)
77. Ozen M, Creighton CJ, Ozdemir M & Ittmann M 2008 Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27 1788-1793. (doi:10.1038/sj.onc.1210809)
78. Pauli A, Norris ML, Valen E, Chew GL, Gagnon JA, Zimmerman S, Mitchell A, Ma J, Dubrulle J, Reyon D et al. 2014 Toddler: an embryonic signal that promotes cell movement via Apelin receptors. Science 343 1248636. (doi:10.1126/science.1248636)
79. Pinho FG, Frampton AE, Nunes J, Krell J, Alshaker H, Jacob J, Pellegrino L, Roca-Alonso L, de Giorgio A, Harding V et al. 2013 Downregulation of microRNA-515-5p by the estrogen receptor modulates sphingosine kinase 1 and breast cancer cell proliferation. Cancer Research 73 5936-5948. (doi:10.1158/0008-5472.CAN-13-0158)
80. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL & Visakorpi T 2007 MicroRNA expression profiling in prostate cancer. Cancer Research 67 6130-6135. (doi:10.1158/0008-5472.CAN-07-0533)
81. Prensner JR, Sahu A, Iyer MK, Malik R, Chandler B, Asangani IA, Poliakov A, Vergara IA, Alshalalfa M, Jenkins RB et al. 2014 The lncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer. Oncotarget 30 1434-1438.
82. Rainer J, Ploner C, Jesacher S, Ploner A, Eduardoff M, Mansha M, Wasim M, Panzer-Grumayer R, Trajanoski Z, Niederegger H et al. 2009 Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia. Leukemia 23 746-752. (doi:10.1038/leu.2008.370)
83. Renthal NE, Chen CC, Williams KC, Gerard RD, Prange-Kiel J & Mendelson CR 2010 miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. PNAS 107 20828-20833. (doi:10.1073/pnas.1008301107)
84. Ribas J, Ni X, Haffner M, Wentzel EA, Salmasi AH, Chowdhury WH, Kudrolli TA, Yegnasubramanian S, Luo J, Rodriguez R et al. 2009 miR-21: an androgen receptor-regulated microRNA that promotes hormonedependent and hormone-independent prostate cancer growth. Cancer Research 69 7165-7169. (doi:10.1158/0008-5472.CAN-09-1448)
85. Rinn JL & Chang HY 2012 Genome regulation by long noncoding RNAs. Annual Review of Biochemistry 81 145-166. (doi:10.1146/annurevbiochem-051410-092902)
86. Ross-Innes CS, Stark R, Holmes KA, Schmidt D, Spyrou C, Russell R, Massie CE, Vowler SL, Eldridge M & Carroll JS 2010 Cooperative interaction between retinoic acid receptor-a and estrogen receptor in breast cancer. Genes and Development 24 171-182. (doi:10.1101/gad.552910)
87. Sahu B, Laakso M, Ovaska K, Mirtti T, Lundin J, Rannikko A, Sankila A, Turunen JP, Lundin M, Konsti J et al. 2011 Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer. EMBO Journal 30 3962-3976. (doi:10.1038/emboj.2011.328)
88. Shi Y, Downes M, Xie W, Kao HY, Ordentlich P, Tsai CC, Hon M & Evans RM 2001 Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. Genes and Development 15 1140-1151. (doi:10.1101/gad.871201)
89. Shi XB, Xue L, Yang J, Ma AH, Zhao J, Xu M, Tepper CG, Evans CP, Kung HJ & deVere White RW 2007 An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. PNAS 104 19983-19988. (doi:10.1073/pnas.0706641104)
90. Shin C, Nam JW, Farh KK, Chiang HR, Shkumatava A & Bartel DP 2010 Expanding themicroRNA targeting code: functional sites with centered pairing. Molecular Cell 38 789-802. (doi:10.1016/j.molcel.2010.06.005)
91. Sober S, Laan M & Annilo T 2010 MicroRNAs miR-124 and miR-135a are potential regulators of the mineralocorticoid receptor gene (NR3C2) expression. Biochemical and Biophysical Research Communications 391 727-732. (doi:10.1016/j.bbrc.2009.11.128)
92. Vreugdenhil E, Verissimo CS, Mariman R, Kamphorst JT, Barbosa JS, Zweers T, Champagne DL, Schouten T, Meijer OC, de Kloet ER et al. 2009 MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain. Endocrinology 150 2220-2228. (doi:10.1210/en.2008-1335)
93. Waltering KK, Porkka KP, Jalava SE, Urbanucci A, Kohonen PJ, Latonen LM, Kallioniemi OP, Jenster G & Visakorpi T 2011 Androgen regulation of micro-RNAs in prostate cancer. Prostate 71 604-614. (doi:10.1002/pros.21276)
94. Wang Q, Li W, Liu XS, Carroll JS, Janne OA, Keeton EK, Chinnaiyan AM, Pienta KJ & Brown M 2007 A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Molecular Cell 27 380-392. (doi:10.1016/j.molcel.2007.05.041)
95. Wang D, Garcia-Bassets I, Benner C, Li W, Su X, Zhou Y, Qiu J, Liu W, Kaikkonen MU, Ohgi KA et al. 2011 Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 474 390-394. (doi:10.1038/nature10006)
96. Wapinski O & Chang HY 2011 Long noncoding RNAs and human disease. Trends in Cell Biology 21 354-361. (doi:10.1016/j.tcb.2011.04.001)
97. Watanabe M, Yanagisawa J, Kitagawa H, Takeyama K, Ogawa S, Arao Y, Suzawa M, Kobayashi Y, Yano T, Yoshikawa H et al. 2001 A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor a coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. EMBO Journal 20 1341-1352. (doi:10.1093/emboj/20.6.1341)
98. Wendler A, Keller D, Albrecht C, Peluso JJ & Wehling M 2011 Involvement of let-7/miR-98 microRNAs in the regulation of progesterone receptor membrane component 1 expression in ovarian cancer cells. Oncology Reports 25 273-279. (doi:10.3892/or_00001071)
99. Xia HF, Jin XH, Song PP, Cui Y, Liu CM & Ma X 2010 Temporal and spatial regulation ofmiR-320 in the uterus during embryo implantation in the rat. International Journal of Molecular Sciences 11 719-730. (doi:10.3390/ijms11020719)
100. Xiao J, Gong AY, Eischeid AN, Chen D, Deng C, Young CY & Chen XM 2012 miR-141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein. Prostate 72 1514-1522. (doi:10.1002/pros.22501)
101. Xiao X, Wang P & Chou KC 2013 Recent progresses in identifying nuclear receptors and their families. Current Topics in Medicinal Chemistry 13 1192-1200. (doi:10.2174/15680266113139990006)
102. Yang L, Lin C, Jin C, Yang JC, Tanasa B, Li W, Merkurjev D, Ohgi KA, Meng D, Zhang J et al. 2013 lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature 500 598-602. (doi:10.1038/nature12451)
103. Zechel C, Shen XQ, Chambon P & Gronemeyer H 1994 The dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements. EMBO Journal 13 1414-1424.
104. Zhao X, Patton JR, Davis SL, Florence B, Ames SJ & Spanjaard RA 2004 Regulation of nuclear receptor activity by a pseudouridine synthase through posttranscriptional modification of steroid receptor RNA activator. Molecular Cell 15 549-558. (doi:10.1016/j.molcel.2004.06.044)
105. Zhao X, Patton JR, Ghosh SK, Fischel-Ghodsian N, Shen L & Spanjaard RA 2007 Pus3p-and Pus1p-dependent pseudouridylation of steroid receptor RNA activator controls a functional switch that regulates nuclear receptor signaling. Molecular Endocrinology 21 686-699. (doi:10.1210/me.2006-0414)
106. Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, Coppola D & Cheng JQ 2008 MicroRNA-221/222 negatively regulates estrogen receptor a and is associated with tamoxifen resistance in breast cancer. Journal of Biological Chemistry 283 31079-31086. (doi:10.1074/jbc.M806041200)